Literature DB >> 26610380

Phosphorylation of JNK Increases in the Cortex of Rat Subjected to Diabetic Cerebral Ischemia.

Yi Ma1, Shihui Sun2, Jingwen Zhang3, Zhirong Chen4, Fengying Guo1, Yanhui Du2, Jianzhong Zhang5.   

Abstract

Previous studies have demonstrated that the c-Jun N-terminal kinase (JNK) pathway plays an important role in inducing neuronal apoptosis following cerebral ischemic injury. JNK signaling pathway in activated during cerebral ischemic injury. It participates in ischemia-induced neuronal apoptosis. However, whether JNK signaling is involved in the process of neuronal apoptosis of diabetes-induced cerebral ischemia is largely unknown. This study was undertaken to evaluate the influence of cerebral ischemia-reperfusion injury on phosphorylation of JNK in diabetic rats. Twenty-four adult streptozotocin induced diabetic and 24 adult non-diabetic rats were randomly subjected to 15 min of forebrain ischemia followed by reperfusion for 0, 1, 3, and 6 h. Sixteen sham-operated diabetic and non-diabetic rats were used as controls. Apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL). Protein expression of phospho-JNK was examined by immunohistochemistry and Western blot. The numbers of TUNEL-positive cells and phospho-JNK protein expression in the cerebral cortices after 1, 3 and 6 h reperfusion was significantly higher in diabetic rats compared to non-diabetic animals subjected to ischemia and reperfusion (p < 0.05). Western blot analysis showed significantly higher phospho-JNK protein expression in the cerebral cortices of the diabetic rats after 1 and 3 h reperfusion than that was presented in non-diabetic animals subjected to ischemia and reperfusion (p < 0.05). These findings suggest that increased phosphorylation of JNK may be associated with diabetes-enhanced ischemic brain damage.

Entities:  

Keywords:  Cerebral ischemia; Diabetes; Reperfusion; Stroke; c-Jun N-terminal kinase

Mesh:

Substances:

Year:  2015        PMID: 26610380     DOI: 10.1007/s11064-015-1753-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.

Authors:  Chirantan Banerjee; Yeseon P Moon; Myunghee C Paik; Tatjana Rundek; Consuelo Mora-McLaughlin; Julio R Vieira; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2012-03-01       Impact factor: 7.914

Review 2.  Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.

Authors:  Sherif Hafez; Maha Coucha; Askiel Bruno; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2014-03-13       Impact factor: 6.829

3.  Bad as a converging signaling molecule between survival PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats.

Authors:  Hiroshi Kamada; Chikako Nito; Hidenori Endo; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-05       Impact factor: 6.200

4.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

5.  Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.

Authors:  Chang Gun Kim; Byeong Hyeok Choi; Sang Wook Son; Seong Joon Yi; Soon Young Shin; Young Han Lee
Journal:  Cell Signal       Date:  2007-01-19       Impact factor: 4.315

6.  Diabetes enhances apoptosis induced by cerebral ischemia.

Authors:  Zhen-guo Li; Mark Britton; Anders A F Sima; Joseph C Dunbar
Journal:  Life Sci       Date:  2004-12-03       Impact factor: 5.037

Review 7.  Ischemia-induced hyperglycemia: consequences, neuroendocrine regulation, and a role for RAGE.

Authors:  Zachary M Weil
Journal:  Horm Behav       Date:  2012-04-11       Impact factor: 3.587

Review 8.  Immune interventions in stroke.

Authors:  Ying Fu; Qiang Liu; Josef Anrather; Fu-Dong Shi
Journal:  Nat Rev Neurol       Date:  2015-08-25       Impact factor: 42.937

Review 9.  Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics.

Authors:  Ashish K Rehni; Neha Nautiyal; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Metab Brain Dis       Date:  2014-04-16       Impact factor: 3.584

10.  COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK Pathway.

Authors:  Hyo Eun Moon; Kyunghee Byun; Hyung Woo Park; Jin Hyun Kim; Jin Hur; Joong Shin Park; Jong Kwan Jun; Hyo-Soo Kim; Seung Leal Paek; In Keyoung Kim; Jae Ha Hwang; Jin Wook Kim; Dong Gyu Kim; Young Chul Sung; Gou-Young Koh; Chang W Song; Bonghee Lee; Sun Ha Paek
Journal:  Exp Neurobiol       Date:  2015-03-13       Impact factor: 3.261

View more
  1 in total

Review 1.  c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury.

Authors:  Maria Shvedova; Yana Anfinogenova; Elena N Atochina-Vasserman; Igor A Schepetkin; Dmitriy N Atochin
Journal:  Front Pharmacol       Date:  2018-07-05       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.